← Leaderboards
Matthew J Wolf
Duke University
$7,663,961
Attributed
$10,683,909
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2007–25$2.5M$1.9M$1.3M$625K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,683,909 · 6
By mechanism
R01$9,608,659 · 4
K08$631,125 · 1
R21$444,125 · 1
Top collaborators
- Jeffrey J. Saucerman5 shared
- Frederick H. Epstein4 shared
Most similar at Duke University
Same institution · by research overlap
- Yvonne Marie Mowery$1,022,685
- Sheila Collins$15,347,398
- Michael Peter Vitek$14,740,646
- Guoping Feng$46,416,541
- Erin L Heinzen$9,592,126
Others in their field
Top investigators on “Signal Transduction”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
- David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Garret A Fitzgerald · University Of Pennsylvania$66,142,222
- Michael Barry Kastan · Duke University$64,512,357
- Randall J Bateman · Washington University$62,939,456
Research focus
Signal TransductionHeart FailureSignal PathwayCardiovascular DiseasesIn VivoAdultCardiac MyocytesCellsBaseGeneticMortalityInnovationCardiacInvestigationMorbidity - Disease RatePathway InteractionsKnock-OutMolecularMyocardiumMouse ModelLeadHeart FunctionGenesCardiomyopathies
Grant awards (26)
Systems Pharmacology Model of Cardiac Hypertrophy$761,655
R01 · FY2025 · HL
Multiparametric MRI for the investigation of coronary microvascular disease$759,343
R01 · FY2025 · HL
Multiparametric MRI for the investigation of coronary microvascular disease$766,414
R01 · FY2024 · HL
Systems Pharmacology Model of Cardiac Hypertrophy$746,423
R01 · FY2024 · HL
DYRK1a as a therapeutic target to treat myocardial infarction$403,750
R01 · FY2024 · HL · contact PI
Diversity Supplement: Systems Pharmacology Model of Cardiac Hypertrophy$50,330
R01 · FY2024 · HL
Multiparametric MRI for the investigation of coronary microvascular disease$783,404
R01 · FY2023 · HL
Systems Pharmacology Model of Cardiac Hypertrophy$761,655
R01 · FY2023 · HL
DYRK1a as a therapeutic target to treat myocardial infarction$403,750
R01 · FY2023 · HL · contact PI
A CRISPR-based modular transgenic system to advance in vivo investigations of angiogenesis and fibrosis$201,875
R21 · FY2023 · OD · contact PI
Systems Pharmacology Model of Cardiac Hypertrophy$761,655
R01 · FY2022 · HL
Multiparametric MRI for the investigation of coronary microvascular disease$649,018
R01 · FY2022 · HL
DYRK1a as a therapeutic target to treat myocardial infarction$403,750
R01 · FY2022 · HL · contact PI
A CRISPR-based modular transgenic system to advance in vivo investigations of angiogenesis and fibrosis$242,250
R21 · FY2022 · OD · contact PI
DYRK1a as a therapeutic target to treat myocardial infarction$403,750
R01 · FY2021 · HL · contact PI
Novel pathways modulating Raf-mediated cardiac hypertrophy$395,000
R01 · FY2017 · HL · contact PI
Novel pathways modulating Raf-mediated cardiac hypertrophy$395,000
R01 · FY2016 · HL · contact PI
Novel pathways modulating Raf-mediated cardiac hypertrophy$238,882
R01 · FY2015 · HL · contact PI
Novel pathways modulating Raf-mediated cardiac hypertrophy$147,730
R01 · FY2015 · HL · contact PI
Novel pathways modulating Raf-mediated cardiac hypertrophy$384,650
R01 · FY2014 · HL · contact PI
Novel pathways modulating Raf-mediated cardiac hypertrophy$392,500
R01 · FY2013 · HL · contact PI
Genetic modifiers of dilated cardiomyopathy in adult Drosophila$126,225
K08 · FY2011 · HL · contact PI
Genetic modifiers of dilated cardiomyopathy in adult Drosophila$126,225
K08 · FY2010 · HL · contact PI
Genetic modifiers of dilated cardiomyopathy in adult Drosophila$126,225
K08 · FY2009 · HL · contact PI
Genetic modifiers of dilated cardiomyopathy in adult Drosophila$126,225
K08 · FY2008 · HL · contact PI
Genetic modifiers of dilated cardiomyopathy in adult Drosophila$126,225
K08 · FY2007 · HL · contact PI